CDVA.CN stock up 50% to C$0.03 in market hours on 17 Feb 2026: monitor earnings

CDVA.CN stock surged 50.00% to C$0.03 in market hours on 17 Feb 2026 after heavy intraday buying pushed volume to 38,000 shares on the CNQ (Canada). This jump came from a low open at C$0.02 and a session high at C$0.03, signalling short-term momentum for CordovaCann Corp. (CDVA.CN). We track how trading flows, fundamentals, and the upcoming earnings date could shape the next moves for this small-cap cannabis equity.

CDVA.CN stock price action and intraday drivers

CordovaCann Corp. (CDVA.CN) moved from an open of C$0.02 to a close of C$0.03, a C$0.01 gain and 50.00% intraday rise. Volume of 38,000 exceeded the 30-day average of 21,677, showing stronger buying interest.

The session gain linked to sector chatter and relative low float dynamics. The company trades on the CNQ in Canada, and short-term traders reacted to peer comparisons on investing.com and to renewed attention to retail store operations.

CDVA.CN stock drivers: news, peers and sector context

Recent screening and peer comparisons raised visibility for CordovaCann, according to market feeds on investing.com. Those comparisons can amplify small-cap moves when volumes pick up. Investing.com: Compare CordovaCann Corp.

Healthcare and cannabis sector weakness year-to-date contrasts with CDVA.CN’s intraday jump. The healthcare sector in Canada has shown negative short-term performance, so isolated stock-level news can drive outsized percentage moves for microcaps.

CDVA.CN stock financials and valuation snapshot

CordovaCann shows a market cap of C$3,294,104.00 with 109,803,460 shares outstanding. Trailing EPS is -0.02 and reported PE is -1.50, reflecting losses. Price averages are 50-day C$0.03 and 200-day C$0.05, and the 52-week range is C$0.01 to C$0.23.

Meyka AI rates CDVA.CN with a score out of 100: 68.63/100, Grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. These grades are model outputs and not financial advice.

CDVA.CN stock technicals, liquidity and trading metrics

Technicals show a neutral RSI at 53.44 and ADX at 36.13, suggesting a strong short-term trend on recent volume spikes. Bollinger bands sit at Upper C$0.04, Middle C$0.03, Lower C$0.01 which aligns with the current C$0.03 price.

Liquidity remains thin for a retail trade: average volume 21,677 shares and current volume 38,000. That relVolume of 1.75 can magnify moves and widen bid-ask spreads on CNQ.

CDVA.CN stock risks and short-term catalysts

Primary risks include continued negative EPS, thin liquidity, and retail cannabis regulatory shifts. CordovaCann’s balance sheet metrics show low cash per share C$0.01 and a current ratio near 0.19, indicating working capital pressure.

Near-term catalysts include the earnings announcement scheduled for 2026-03-04 and any operational updates about the Star Buds retail footprint. Traders should watch changes in average volume, insider activity, and competitor news.

CDVA.CN stock forecast and price targets

Meyka AI’s forecast model projects a monthly level at C$0.05 and a quarterly target at C$0.06. From the current C$0.03, the model implies an upside of 66.67% to the monthly target and 100.00% to the quarterly target. Forecasts are model-based projections and not guarantees.

Analyst-style targets for scenarios: conservative near-term target C$0.05, base-case quarterly C$0.06, upside on a positive earnings surprise C$0.12. Use tight risk controls given the stock’s microcap status and volatility.

Final Thoughts

CordovaCann Corp. (CDVA.CN) led today’s top gainers on CNQ, rising 50.00% to C$0.03 on above-average volume. That move reflects low float sensitivity and renewed attention from peer-comparison tools. Fundamentals remain mixed: EPS is -0.02, market cap is C$3,294,104.00, and liquidity is thin. Meyka AI’s forecast model projects C$0.05 monthly and C$0.06 quarterly levels, implying 66.67% and 100.00% upside respectively from the current price. These projections are model-based and not guarantees. For traders, the March 2026-03-04 earnings date is the next clear catalyst. Investors should weigh speculative upside against working capital pressure and sector headwinds. For a quick stock page and real-time updates, see the CordovaCann listing on Meyka AI: CordovaCann on Meyka AI and monitoring via industry comparisons on investing.com can provide context for short-term moves. Remember, this analysis is informational and not investment advice.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.